Isolierte systolische Hypertonie

M. van der Giet

doi:10.1055/s-2005-922050

DMW - Deutsche Medizinische Wochenschrift, Table of Contents

Dtsch Med Wochenschr 2005; 130(46): 2653-2656
DOI: 10.1055/s-2005-922050

Übersichten

Hypertensiologie
© Georg Thieme Verlag Stuttgart · New York

Isolierte systolische Hypertonie

Isolated systolic hypertensionM. van der Giet¹

¹Medizinische Klinik IV - Nephrologie, Charite - Campus Benjamin Franklin, Berlin

Abstract

Full Text

References

Literatur

1 The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group . Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension. J Clin Epidemiol. 1988; 41 1197-1208
2 SHEP Cooperative Research Group . Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). Jama. 1991; 265 3255-3264
3 Arking D E, Atzmon G, Arking A, Barzilai N, Dietz H C. Association between the functional variant of KLOTHO allele and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ Res. 2005; 96 412-418
4 Asmar R, Gosse P, Topouchian J, N’Tela G, Dudley A, Shepherd G L. Effects of telmisartan on arterial stiffness in Type 2 diabetes patients with essential hypertension. J Renin Angiotensin Aldosterone Syst. 2002; 3 176-180
5 Asmar R, Hugues C, Pannier B, Daou J, Safar M E. Duration of action of bisoprolol after cessation of a 4 week treatment and its influence on pulse wave velocity and aortic diameter: a pilot study in hypertensive patients. Eur Heart J. 1987; 8 (Suppl M) 115-120
6 Asmar R G, London G M, O’Rourke M E, Safar M E. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension. 2001; 38 922-926
7 Bailey M, Pillarisetti S, Jones P, Xiao H, Simionescu D, Vyavahare N. Involvement of matrix metalloproteinases and tenascin-C in elastin calcification. Cardiovasc Pathol. 2004; 13 146-155
8 Benetos A et al. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation. 2002; 105 1202-1207
9 Benetos A, Vasmant D, Thiery P, Safar M. Effects of ramipril on arterial hemodynamics. J Cardiovasc Pharmacol. 1991; 18 S153-156 (Suppl 2)
10 Blacher J, Raison J, Amah G, Schiemann A L, Stimpel M, Safar M E. Increased arterial distensibility in postmenopausal hypertensive women with and without hormone replacement therapy after acute administration of the ACE inhibitor moexipril. Cardiovasc Drugs Ther. 1998; 12 409-414
11 Blacher J, Staessen J A, Girerd X, Gasowski J, Thijs L, Liu L, Wang J G, Fagard R H, Safar M E. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med. 2000; 160 1085-1089
12 Bortolotto L A, Safar M E, Billaud E, Lacroix C, Asmar R, London G M, Blacher J. Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. Hypertension. 1999; 34 837-842
13 Burt V L, Cutler J A, Higgins M, Horan M J, Labarthe D, Whelton P, Brown C, Roccella E J. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension. 1995; 26 60-69
14 Burt V L, Whelton P, Roccella E J, Brown C, Cutler J A, Higgins M, Horan M J, Labarthe D. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988 - 1991. Hypertension. 1995; 25 305-313
15 Chae C U, Pfeffer M A, Glynn R J, Mitchell G F, Taylor J O, Hennekens C H. Increased pulse pressure and risk of heart failure in the elderly. Jama. 1999; 281 634-639
16 Domanski M J, Davis B R, Pfeffer M A, Kastantin M, Mitchell G F. Isolated systolic hypertension: prognostic information provided by pulse pressure. Hypertension. 1999; 34 375-380
17 Ferrier K E, Muhlmann M H, Baguet J P, Cameron J D, Jennings G L, Dart A M, Kingwell B A. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol. 2002; 39 1020-1025
18 Franklin S S, Gustin W t, Wong N D, Larson M G, Weber M A, Kannel W B, Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997; 96 308-315
19 Franklin S S, Khan S A, Wong N D, Larson M G, Levy D. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation. 1999; 100 354-360
20 Izzo J L, Shykoff B E. Arterial stiffness: clinical relevance, measurement, and treatment. Rev Cardiovasc Med. 2001; 2 29-34, 37 - 40
21 Kannel W B, Gordon T, Schwartz M J. Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol. 1971; 27 335-346
22 Kass D A, Shapiro E P, Kawaguchi M, Capriotti A R, Scuteri A, deGroof R C, Lakatta E G. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation. 2001; 104 1464-1470
23 Komai N, Ohishi M, Moriguchi A. et al . Low-dose doxazosin improved aortic stiffness and endothelial dysfunction as measured by noninvasive evaluation. Hypertens Res. 2002; 25 5-10
24 Kostis J B, Lawrence-Nelson J, Ranjan R, Wilson A C, Kostis W J, Lacy C R. Association of increased pulse pressure with the development of heart failure in SHEP. Systolic Hypertension in the Elderly (SHEP) Cooperative Research Group. Am J Hypertens. 2001; 14 798-803
25 Kuro-o M, Matsumura Y. et al . Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997; 390 45-51
26 Lehmann E D. Terminology for the definition of arterial elastic properties. Pathol Biol (Paris). 1999; 47 656-664
27 Lichtenstein M J, Shipley M J, Rose G. Systolic and diastolic blood pressures as predictors of coronary heart disease mortality in the Whitehall study. Br Med J (Clin Res Ed). 1985; 291 243-245
28 Liu L, Wang J G, Gong L, Liu G, Staessen J A. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens. 1998; 16 1823-1829
29 McEniery C M, Wallace S, Dakham Z, Pusalkar P, Ashby M J, Cockcroft J R, Wilkinson I B. Matrix Metalloproteinase-9 (MMP-9), MMP-2, and Serum Elastase Activity Are Associated With Systolic Hypertension and Arterial Stiffness. Arterioscler Thromb Vasc Biol. 2005; 25 372-378
30 Mitchell G F, Parise H, Benjamin E J, Larson M G, Keyes M J, Vita J A, Vasan R S, Levy D. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension. 2004; 43 1239-1245
31 Morgan T, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens. 2004; 17 118-123
32 Neaton J D, Blackburn H. et al . Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992; 152 1490-1500
33 Nicholls W W, Avolioa A P, Kelly R P. Effects of age and of hypertension on wave travel and reflections. London: Edward Arnold In: O’Rourke MF, Safa M, dzau VJ, eds. Arterial vasodilation: mechanisms and therapy 1993: 23-40
34 Nurnberger J, Opazo Saez A, Dammer S, Mitchell A, Wenzel R R, Philipp T, Schafers R F. Left ventricular ejection time: a potential determinant of pulse wave velocity in young, healthy males. J Hypertens. 2003; 21 2125-2132
35 Robert L. Aging of the vascular-wall and atherosclerosis. Exp Gerontol. 1999; 34 491-501
36 Rutan G H, Kuller L H, Neaton J D, Wentworth D N, McDonald R H, Smith W M. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation. 1988; 77 504-514
37 Seals D R. et al . Blood pressure reductions with exercise and sodium restriction in postmenopausal women with elevated systolic pressure: role of arterial stiffness. J Am Coll Cardiol. 2001; 38 506-513
38 Staessen J A, Fagard R. et al . Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997; 350 757-764
39 Staessen J A. et al . Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000; 355 865-872
40 Tavli T, Kozan O, Cin V G, Dogan A, Gokcin A. The effects of nisoldipine on carotid artery stiffness and left ventricular functions. Jpn Heart J. 1995; 36 629-637
41 Tomiyama H. et al . Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement - a survey of 12 517 subjects. Atherosclerosis. 2003; 166 303-309
42 Vaccarino V, Holford T R, Krumholz H M. Pulse pressure and risk for myocardial infarction and heart failure in the elderly. J Am Coll Cardiol. 2000; 36 130-138
43 Wilking S V, Belanger A, Kannel W B, D’Agostino R B, Steel K. Determinants of isolated systolic hypertension. J Am Med Assoc. 1988; 260 3451-3455

Prof. Dr. med. Markus van der Giet

Charite - Campus Benjamin Franklin, Medizinische Klinik IV - Nephrologie

Hindenburgdamm 30

12200 Berlin

Phone: +4930/84453021

Fax: +4930/84453338

Email: markus.vandergiet@charite.de